(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIDORES DE PROTEASES DE CISTEÍNA E MÉTODOS DE USO DAS MESMAS

ArquivadaInvention PatentPCT · US2021036638

Application data

Number

112021023814

Type

Invention Patent

Filing

06/09/2021

Publication

12/20/2022

PCT

US2021036638

Progress at the INPI

  1. Filing06/09/21
  2. Publication12/20/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 06/09/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/03/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PARDES BIOSCIENCES, INC.

US

Inventors

A. J. (pessoa física)

US

L. A. (pessoa física)

US

W. K. (pessoa física)

US

Technical data

Priority claims

US

63/036,866 · 06/09/2020

US

63/039,297 · 06/15/2020

US

63/067,669 · 08/19/2020

US

63/091,630 · 10/14/2020

US

63/129,018 · 12/22/2020

US

63/171,675 · 04/07/2021

US

63/172,478 · 04/08/2021

US

63/173,146 · 04/09/2021

US

63/179,128 · 04/23/2021

US

63/195,460 · 06/01/2021

Abstract

A invenção fornece compostos com grupos reativos e seu uso no tratamento de doenças ou distúrbios médicos, tais como infecções virais. São fornecidas composições farmacêuticas e métodos de fabricação de vários compostos com grupos reativos. Os compostos são contemplados para inibir proteases, tais como a protease semelhante a 3C, CL- ou 3CL.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

09/03/2024

RPI 2800

Arquivamento - Art. 33 da LPI

#11.1

06/18/2024

RPI 2789

Notificação de entrada na fase nacional - PCT

#1.3

12/20/2022

RPI 2711

Alteração de dados cadastrais

#1.1

02/01/2022

RPI 2665

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.